Tau Stabilizes Chromatin Compaction
Document type :
Article dans une revue scientifique: Article original
PMID :
Title :
Tau Stabilizes Chromatin Compaction
Author(s) :
Rico, Thomas [Auteur]
Lille Neurosciences & Cognition - U 1172 [LilNCog]
Gilles, Melissa [Auteur]
Lille Neurosciences & Cognition - U 1172 [LilNCog]
Chauderlier, Alban [Auteur]
Lille Neurosciences & Cognition - U 1172 [LilNCog]
Comptdaer, Thomas [Auteur]
Lille Neurosciences & Cognition - U 1172 [LilNCog]
Magnez, Romain [Auteur]
Hétérogénéité, Plasticité et Résistance aux Thérapies des Cancers = Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 [CANTHER]
Chwastyniak, Maggy [Auteur]
Facteurs de Risque et Déterminants Moléculaires des Maladies liées au Vieillissement - U 1167 [RID-AGE]
Drobecq, Herve [Auteur]
Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204 [CIIL]
PINET, FLORENCE [Auteur]
Facteurs de Risque et Déterminants Moléculaires des Maladies liées au Vieillissement - U 1167 [RID-AGE]
Thuru, Xavier [Auteur]
Hétérogénéité, Plasticité et Résistance aux Thérapies des Cancers = Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 [CANTHER]
Buee, Luc [Auteur]
Lille Neurosciences & Cognition - U 1172 [LilNCog]
Galas, Marie-Christine [Auteur]
Lille Neurosciences & Cognition - U 1172 [LilNCog]
Lefebvre, Bruno [Auteur correspondant]
Lille Neurosciences & Cognition - U 1172 [LilNCog]
Lille Neurosciences & Cognition - U 1172 [LilNCog]
Gilles, Melissa [Auteur]
Lille Neurosciences & Cognition - U 1172 [LilNCog]
Chauderlier, Alban [Auteur]
Lille Neurosciences & Cognition - U 1172 [LilNCog]
Comptdaer, Thomas [Auteur]
Lille Neurosciences & Cognition - U 1172 [LilNCog]
Magnez, Romain [Auteur]
Hétérogénéité, Plasticité et Résistance aux Thérapies des Cancers = Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 [CANTHER]
Chwastyniak, Maggy [Auteur]
Facteurs de Risque et Déterminants Moléculaires des Maladies liées au Vieillissement - U 1167 [RID-AGE]
Drobecq, Herve [Auteur]
Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204 [CIIL]
PINET, FLORENCE [Auteur]

Facteurs de Risque et Déterminants Moléculaires des Maladies liées au Vieillissement - U 1167 [RID-AGE]
Thuru, Xavier [Auteur]

Hétérogénéité, Plasticité et Résistance aux Thérapies des Cancers = Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 [CANTHER]
Buee, Luc [Auteur]

Lille Neurosciences & Cognition - U 1172 [LilNCog]
Galas, Marie-Christine [Auteur]

Lille Neurosciences & Cognition - U 1172 [LilNCog]
Lefebvre, Bruno [Auteur correspondant]
Lille Neurosciences & Cognition - U 1172 [LilNCog]
Journal title :
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
Pages :
740550
Publisher :
Frontiers media
Publication date :
2021-10-14
ISSN :
2296-634X
English keyword(s) :
Tau protein (Tau)
chromatin remodeling
chromatin regulation
histone modification and chromatin structure
histone deacetylase inhibitor (HDAC inhibitor)
histone (de)acetylation
cancer biology
chromatin remodeling
chromatin regulation
histone modification and chromatin structure
histone deacetylase inhibitor (HDAC inhibitor)
histone (de)acetylation
cancer biology
HAL domain(s) :
Sciences du Vivant [q-bio]
English abstract : [en]
An extensive body of literature suggested a possible role of the microtubule-associated protein Tau in chromatin functions and/or organization in neuronal, non-neuronal, and cancer cells. How Tau functions in these processes ...
Show more >An extensive body of literature suggested a possible role of the microtubule-associated protein Tau in chromatin functions and/or organization in neuronal, non-neuronal, and cancer cells. How Tau functions in these processes remains elusive. Here we report that Tau expression in breast cancer cell lines causes resistance to the anti-cancer effects of histone deacetylase inhibitors, by preventing histone deacetylase inhibitor-inducible gene expression and remodeling of chromatin structure. We identify Tau as a protein recognizing and binding to core histone when H3 and H4 are devoid of any post-translational modifications or acetylated H4 that increases the Tau’s affinity. Consistent with chromatin structure alterations in neurons found in frontotemporal lobar degeneration, Tau mutations did not prevent histone deacetylase-inhibitor-induced higher chromatin structure remodeling by suppressing Tau binding to histones. In addition, we demonstrate that the interaction between Tau and histones prevents further histone H3 post-translational modifications induced by histone deacetylase-inhibitor treatment by maintaining a more compact chromatin structure. Altogether, these results highlight a new cellular role for Tau as a chromatin reader, which opens new therapeutic avenues to exploit Tau biology in neuronal and cancer cells.Show less >
Show more >An extensive body of literature suggested a possible role of the microtubule-associated protein Tau in chromatin functions and/or organization in neuronal, non-neuronal, and cancer cells. How Tau functions in these processes remains elusive. Here we report that Tau expression in breast cancer cell lines causes resistance to the anti-cancer effects of histone deacetylase inhibitors, by preventing histone deacetylase inhibitor-inducible gene expression and remodeling of chromatin structure. We identify Tau as a protein recognizing and binding to core histone when H3 and H4 are devoid of any post-translational modifications or acetylated H4 that increases the Tau’s affinity. Consistent with chromatin structure alterations in neurons found in frontotemporal lobar degeneration, Tau mutations did not prevent histone deacetylase-inhibitor-induced higher chromatin structure remodeling by suppressing Tau binding to histones. In addition, we demonstrate that the interaction between Tau and histones prevents further histone H3 post-translational modifications induced by histone deacetylase-inhibitor treatment by maintaining a more compact chromatin structure. Altogether, these results highlight a new cellular role for Tau as a chromatin reader, which opens new therapeutic avenues to exploit Tau biology in neuronal and cancer cells.Show less >
Language :
Anglais
Peer reviewed article :
Oui
Audience :
Internationale
Popular science :
Non
ANR Project :
Source :
Files
- https://hal.archives-ouvertes.fr/hal-03429442/document
- Open access
- Access the document
- https://hal.archives-ouvertes.fr/hal-03429442/document
- Open access
- Access the document
- document
- Open access
- Access the document
- fcell-09-740550.pdf
- Open access
- Access the document
- Open access
- Access the document
- document
- Open access
- Access the document
- fcell-09-740550.pdf
- Open access
- Access the document